Organigram Global Inc. · TSX:OGI
Organigram Global — Q1 2021 Earnings Presentation
14 slides from Organigram Global's earnings presentation, Jan 12, 2021
Slide 1: Organigram Q1 Fiscal 2021 Results
ORGANIGRAM Q1 FISCAL 2021 RESULTS JANUARY 12, 2021 NASDAQ (OGI) TSX (OGI)
Slide 2: Cautionary Statement
CAUTIONARY STATEMENT This document is current as of January 10, 2021, except where otherwise stated. The information and the sufficiency of the retail networks to supply such demand; ability to enter and participate in contained in this presentation is provided by Organigram (“OGI” or the “Company”)
Slide 3: Organigram at a Glance
ORGANIGRAM AT A GLANCE LEADING LICENSED 3 LEVEL INDOOR CANADIAN INNOVATION PRODUCER GROWING PROVINCES Leading licensed Focused on Indoor facility in Sales to all continuous producer (LP) Moncton, NB with 10 Canadian improvement, of quality products for unique three-level provinces innovation and Med
Slide 4: Q1 Fiscal 2021 Key Financial Highlights
Q1 FISCAL 2021 KEY FINANCIAL HIGHLIGHTS • Double digit % growth in adult-use recreational market • Generated positive cash revenue flow from operations (CFO) ADULT-USE REC ADULT-USE REC ADULT-USE REC GROSS REVENUE NET REVENUE GROSS REVENUE ADULT-USE REC NET REVENUE in Q1 F2021 22,545 22,545 • 2nd qu
Slide 5: Organigram Adult Recreational Brands
ORGANIGRAM ADULT RECREATIONAL BRANDS #1 MOST SEARCHED MOST-SEARCHED brands on One of top 12 MOST for November and SEARCHED December 2020 Ontario Cannabis Store website for November 2020 Pricing Value Value Value Segment Mainstream Whole Flower, Whole Flower, Available / Pre-Milled Flower, Pre-Roll J
Slide 6: Product Portfolio Revitalization
PRODUCT PORTFOLIO REVITALIZATION Q4 F2020 Q1 F2021 Q2 F2021 53 NEW SKUS LAUNCHED FLOWER Up to 14 Edison 3.5g Black Cherry Punch, FLOWER FLOWER FLOWER Limited Time Offers DISSOLVABLE I.C.C. Buds 28g Edison new high SHRED RE:Mix launch in Ontario THC strains pre-shredded FLOWER Trailblazer Dissolvable
Slide 7: OGI Vaporizer Pen Portfolio
REC 2.0 OGI VAPORIZER PEN PORTFOLIO • Vape portfolio includes offerings for value, mainstream and premium segments of the market • Selected as one of the Canadian partners for PAX ERA, the premium closed loop vaporizer system created by PAX Labs, Inc. • Selected as exclusive Canadian supplier of Fea
Slide 8: Cannabis-Infused Chocolates
REC 2.0 CANNABIS-INFUSED CHOCOLATES • ~$15M investment in high-speed, high-capacity, fully-automated production line that includes advanced engineering, robotics, high-speed labeling, automated carton packing • Launched first product in February 2020, Edison Bytes, premium truffles in milk and dark
Slide 9: Edison Re:Mix
REC 2.0 PROPRIETARY NANOEMULSIFICATION TECHNOLOGY EDISON RE:MIX • Proprietary nanoemulsion technology developed by internal R&D team • Nanoemulsion offers improved absorption when compared to traditional edibles and beverages • Customizable: can easily be added to almost any beverage • Rapid: dissol
Slide 10: OGI's Largest International Deal to Date
OGI’S LARGEST INTERNATIONAL DEAL TO DATE • On June 9, 2020, entered into a multi-year agreement for supply of dried flower to one of Israel’s largest and most established medical cannabis producers, Canndoc Ltd., a pioneer in pharmaceutical-grade cannabis for > 12 years • Canndoc’s GMP-approved medi
Slide 11: Liquidity and Capital Resources
LIQUIDITY AND CAPITAL RESOURCES • Generated positive cash flow from operations of $0.3 million in Q1 Fiscal 2021 • On the back of strong institutional support, opportunistically raised $69 million in gross proceeds from an underwritten public offering • On November 27, 2020, amended the credit facil
Slide 12: Canadian Adult-Use Rec Market Size and Growth
CANADIAN ADULT-USE REC MARKET SIZE AND GROWTH NUMBER OF CANNABIS RETAIL STORES NUMBER OF ONTARIO RETAIL STORE AUTHORIZATIONS PER MONTH Jul- Jan- 2020 2021 Ontario Sept-2020 Today* RECORD Ontario $3.2B 102 330 Rest of Rest of Canadian Canadian MARKET provinces provinces 861 1034 Annualized run rate1
Slide 13: Q1 Fiscal 2021 Key Financial Metrics
Q1 FISCAL 2021 KEY FINANCIAL METRICS Select Key Financial Metrics (in $000s) unless otherwise Q1 2021 Q1 2020 % Change indicated Gross revenue 25,280 28,448 -11% Excise taxes (5,949) (3,295) 81% Net revenue 19,331 25,153 -23% Cost of sales 23,173 15,811 47% Gross margin before fair value changes to
Slide 14: Q1 Fiscal 2021 Key Balance Sheet and Share Metrics
Q1 FISCAL 2021 KEY BALANCE SHEET and SHARE METRICS Select Balance Sheet Metrics (in $000s) 30-Nov-20 31-Aug-20 % Change Cash & short-term investments 133,900 74,728 79% Biological assets & inventories 53,921 71,759 -25% Other current assets 20,556 23,717 -13% Accounts payable & accrued liabilities 1